|
Market Closed -
Nasdaq
16:00:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 16.60 USD | -3.49% |
|
-2.70% | +108.54% |
| 08-24 | Personalis Shares Fall After Craig-Hallum Downgrade | MT |
| 08-24 | Craig-Hallum Downgrades Personalis to Hold From Buy, Price Target is $16.25 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PERSONALIS, INC. | Other Biotechnology & Medical Research | -3.49% | -2.70% | +108.54% | +212.03% | -25.06% | 1.77B |  | | |
- Stock Market
- Stocks
- PSNL Stock
- Charts Personalis, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
